Marketing-authorisation holder · Canada
Organon Canada Inc.
71 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Canada
71 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 71
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ASMANEX TWISTHALER400 mcg / act · Powder | Mometasone | Canada | Marketed | 2011 |
| ASMANEX TWISTHALER100 mcg / act · Powder | Mometasone | Canada | Marketed | 2015 |
| ASMANEX TWISTHALER200 mcg / act · Powder | Mometasone | Canada | Marketed | 2011 |
| CELESTONE SOLUSPAN3 mg / ml + 3 mg / ml · Suspension | Betamethasone | Canada | Marketed | 1965 |
| COTAZYM40000 unit + 10000 unit + 35000 unit · Capsule (Immediate-Release) | Amylase, Lipase, Protease | Canada | Marketed | 1973 |
| COTAZYM ECS 20100000 unit + 25000 unit + 100000 unit · Capsule (Delayed-Release) | Amylase, Lipase, Protease | Canada | Marketed | 1989 |
| COTAZYM ECS 842000 unit + 10800 unit + 45000 unit · Capsule (Delayed-Release) | Amylase, Lipase, Protease | Canada | Marketed | 1980 |
| COZAAR50 mg · Tablet | Losartan | Canada | Marketed | 1995 |
| COZAAR25 mg · Tablet | Losartan | Canada | Marketed | 1995 |
| COZAAR100 mg · Tablet | Losartan | Canada | Marketed | 1998 |
| DIPROLENE0.05 % / w/w · Ointment | Betamethasone | Canada | Marketed | 1985 |
| DIPROSALIC0.5 mg / g + 30 mg / g · Ointment | Betamethasone, Salicylic acid | Canada | Marketed | 1983 |
| DIPROSONE0.05 % / w/w · Lotion | Betamethasone | Canada | Marketed | 1977 |
| DIPROSONE0.05 % / w/w · Cream | Betamethasone | Canada | Marketed | 1975 |
| DIPROSONE0.05 % / w/w · Ointment | Betamethasone | Canada | Marketed | 1976 |
| ELOCOM0.1 % · Cream | Mometasone | Canada | Marketed | 1991 |
| ELOCOM0.1 % · Lotion | Mometasone | Canada | Marketed | 1991 |
| ELOCOM0.1 % · Ointment | Mometasone | Canada | Marketed | 1991 |
| ESTROGEL0.06 % / w/w · Gel | Estradiol | Canada | Marketed | 1998 |
| EZETROL10 mg · Tablet | Ezetimibe | Canada | Marketed | 2003 |
| FOSAMAX70 mg · Tablet | Alendronic acid | Canada | Marketed | 2002 |
| FOSAVANCE70 mg + 5600 unit · Tablet | Alendronic acid, Vitamin d | Canada | Marketed | 2008 |
| FOSAVANCE70 mg + 2800 unit · Tablet | Alendronic acid, Vitamin d | Canada | Marketed | 2006 |
| HYZAAR12.5 mg + 100 mg · Tablet | Hydrochlorothiazide, Losartan | Canada | Marketed | 2007 |
| HYZAAR12.5 mg + 50 mg · Tablet | Hydrochlorothiazide, Losartan | Canada | Marketed | 1996 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 71 | 66 | 5 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.